Janus Henderson Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,030
Closed -$123K 2559
2023
Q3
$123K Hold
2,030
﹤0.01% 2482
2023
Q2
$133K Sell
2,030
-2
-0.1% -$146 ﹤0.01% 2537
2023
Q1
$130K Buy
2,032
+935
+85% +$107K ﹤0.01% 2583
2022
Q4
$152K Buy
+1,097
New +$155K ﹤0.01% 2253
2022
Q2
Sell
-682
Closed -$66K 2604
2022
Q1
$66K Hold
682
﹤0.01% 2606
2021
Q4
$136K Buy
+682
New +$161K ﹤0.01% 2466
2020
Q2
Sell
-1,277
Closed -$760K 1314
2020
Q1
$760K Sell
1,277
-978
-43% -$953K ﹤0.01% 1135
2019
Q4
$2.56M Buy
+2,255
New +$2.45M ﹤0.01% 1136
2018
Q3
Sell
-170
Closed -$345K 1450
2018
Q2
$345K Buy
+170
New +$387K ﹤0.01% 1321
2017
Q3
Sell
-3,860
Closed -$5.25M 1293
2017
Q2
$5.25M Buy
+3,860
New +$4.66M ﹤0.01% 976
2015
Q3
Sell
-386
Closed -$842K 837
2015
Q2
$842K Buy
+386
New +$786K 0.01% 710

Other funds holding BLUE

Janus Henderson Group's BLUE Position: Q4 2023 in Review

Janus Henderson Group sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 2,030 shares — an estimated $123K sold.

Janus Henderson Group first reported a position in BLUE in Q2 2015 and held it in 11 quarters. The position peaked at $5.25M in Q2 2017. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Janus Henderson Group reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • Janus Henderson Group sold 2,030 bluebird bio shares in Q4 2023, an estimated $123K.
  • Janus Henderson Group first reported a position in bluebird bio in Q2 2015 and held it in 11 quarters.
  • Janus Henderson Group's bluebird bio position peaked at $5.25M in Q2 2017.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.